New report from clarivate and healthcare executive explores mainland china's biopharma revolution and increasing global influence

New report analyses mainland china's transformation into a global biopharma powerhouse, with key insights for international stakeholders london , nov. 18, 2024 /prnewswire/ -- clarivate plc (nyse:clvt) a leading global provider of transformative intelligence, in partnership with healthcare executive, published by the china pharmaceutical enterprises association, today announced the release of a new report, a decade of innovation, a decade to come . over the past decade, mainland china's biopharmaceutical sector has rapidly advanced to become a global leader in innovation, ranking among the top three for initial drug launches.
CLVT Ratings Summary
CLVT Quant Ranking